Category: Healthcare
Selection will refresh the page with new results

Healthcare Alert: Eli Lilly Dismisses Lawsuit Against...

In the summer and fall of 2023, certain pharmaceutical companies, such as Novo Nordisk (Ozempic, Wegovy, and Rybelsus) and Eli Lilly (Mounjaro), filed lawsuits across the country against medical spas... Read More >

Mandelbaum Barrett PC Secures Reversal of District Court...

On Monday, April 15, 2024, the United States Court of Appeals for the Third Circuit issued a groundbreaking precedential decision in favor of several of our medical provider clients. The appeal was... Read More >

Mandelbaum Barrett PC Secures Non-Profit Status for an...

Mandelbaum Barrett PC’s healthcare and non-profit tax law teams have secured IRS recognition of non-profit status on behalf of an independent medical professional corporation, as an... Read More >

Healthcare Alert: Victory Before the New Jersey Board of...

Background/Procedural History: In May 2019, after a federal jury trial in Boston, the founder and four former executives of Insys Therapeutics Inc. were convicted in connection with bribing medical... Read More >

Mandelbaum Barrett PC’s Healthcare Litigation Team...

In a lawsuit by former members of a multi-specialty practice, the former members sought an order from the court that would have voided the restrictive covenants in the practice’s operating... Read More >

Mandelbaum Barrett PC Secures Dismissal of All Claims in...

Allstate sued our clients, both medical providers and individual physicians, who were reimbursed for medical treatment under the New Jersey No-Fault Law, alleging violations of the New Jersey... Read More >

Mandelbaum Barrett PC’s Healthcare Team Secures Complete...

In March 2020, New Jersey became the epicenter of the global COVID-19 pandemic. As the pandemic spread, our client, a board-certified vascular and general neurologist, worked 24-hour,... Read More >

Mandelbaum Barrett PC Secures Favorable Settlement of False ...

In an action filed by certain patients of the pharmacy as Relators under the federal False Claims Act (the “FCA”), the Relators contended, on behalf of the United States, that the pharmacy... Read More >